Journal of Neurology Neurosurgery & Psychiatry · 2023 · 30 citations · 30 references
Life SciencesInfectious DiseasesNeurologyAutoimmunityImmunopathologyNeuroimmunologyAutoantibodiesAutoantigensAutoimmune BiomarkersAutoimmune DiseasesAutoimmune Neurological DisordersEncephalitisCerebrospinal Fluid Antibody TestingCerebrospinal Fluid AutoantibodiesCerebrospinal Fluid Autoimmune DiagnosticsCns AutoantibodiesNeuronal AutoantibodiesTissue AutoantibodiesTissue-based SerologyViral Encephalitis
To explore the autoimmune response and outcome in the central nervous system (CNS) at the onset of viral infection and correlation between autoantibodies and viruses. Methods A retrospective observational study was conducted in 121 patients (2016–2021) with a CNS viral infection confirmed via cerebrospinal fluid (CSF) next-generation sequencing (cohort A). Their clinical information was analysed and CSF samples were screened for autoantibodies against monkey cerebellum by tissue-based assay. In situ hybridisation was used to detect Epstein-Barr virus (EBV) in brain tissue of 8 patients with glial fibrillar acidic protein (GFAP)-IgG and nasopharyngeal carcinoma tissue of 2 patients with GFAP-IgG as control (cohort B). Results Among cohort A (male:female=79:42; median age: 42 (14–78) years old), 61 (50.4%) participants had detectable autoantibodies in CSF. Compared with other viruses, EBV increased the odds of having GFAP-IgG (OR 18.22, 95% CI 6.54 to 50.77, p<0.001). In cohort B, EBV was found in the brain tissue from two of eight (25.0%) patients with GFAP-IgG. Autoantibody-positive patients had a higher CSF protein level (median: 1126.00 (281.00–5352.00) vs 700.00 (76.70–2899.00), p<0.001), lower CSF chloride level (mean: 119.80±6.24 vs 122.84±5.26, p=0.005), lower ratios of CSF-glucose/serum-glucose (median: 0.50[0.13-0.94] vs 0.60[0.26-1.23], p =0.003), more meningitis (26/61 (42.6%) vs 12/60 (20.0%), p=0.007) and higher follow-up modified Rankin Scale scores (1 (0–6) vs 0 (0–3), p=0.037) compared with antibody-negative patients. A Kaplan-Meier analysis revealed that autoantibody-positive patients experienced significantly worse outcomes (p=0.031). Conclusions Autoimmune responses are found at the onset of viral encephalitis. EBV in the CNS increases the risk for autoimmunity to GFAP.
30
Thaís Armangué, Marianna Spatola, Alexandru Vlagea et al. · The Lancet Neurology · 2018 · 648 citations · Full text
Life Sciences, Immunology, Neurology +16
Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin
Josep Dalmau, Lutz Harms, Markus Höltje et al. · Neurology · 2010 · 631 citations
Medicine, Neurology, Neuroscience +13
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
Boyan Fang, Andrew McKeon, Shannon R. Hinson et al. · JAMA Neurology · 2016 · 550 citations
Life Sciences, Immunology, Neurology +17
Herpes simplex virus encephalitis is a trigger of brain autoimmunity
Thaís Armangué, Frank Leypoldt, Ignacio Málaga et al. · Annals of Neurology · 2013 · 453 citations · Full text